Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Cancer Prevention Research (Philadelphia, Pa.)|September 10, 2009
Concordant DNA methylation in synchronous colorectal carcinomasKazuo Konishi, Lanlan Shen, Jaroslav Jelinek, et al.
Journal of Thoracic Disease|April 12, 2021
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)Iuliia Topchu, Nikolai Karnaukhov, Alexandra Mazitova, et al.
Molecular Cancer Therapeutics|December 17, 2016
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer EpigenomeNoël J-M Raynal, Elodie M Da Costa, Justin T Lee, et al.
Clinical Epigenetics|July 24, 2019
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemiaWoonbok Chung, Andrew D Kelly, Patricia Kropf, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Patient-Derived Three-Dimensional Lung Tumor Models to Evaluate Response to ImmunotherapyKayla F Goliwas, Kenneth P Hough, Sruti Sivan, et al.
Research Square|January 30, 2023
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicryNan Bai, Yusuf Adeshina, Igor Bychkov, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancerLanlan Shen, Minoru Toyota, Yutaka Kondo, et al.
Pageof 25